113 related articles for article (PubMed ID: 18669603)
1. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
McKeen HD; McAlpine K; Valentine A; Quinn DJ; McClelland K; Byrne C; O'Rourke M; Young S; Scott CJ; McCarthy HO; Hirst DG; Robson T
Endocrinology; 2008 Nov; 149(11):5724-34. PubMed ID: 18669603
[TBL] [Abstract][Full Text] [Related]
2. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
Davies TH; Ning YM; Sánchez ER
Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.
McKeen HD; Brennan DJ; Hegarty S; Lanigan F; Jirstrom K; Byrne C; Yakkundi A; McCarthy HO; Gallagher WM; Robson T
Biochem Soc Trans; 2011 Apr; 39(2):663-8. PubMed ID: 21428958
[TBL] [Abstract][Full Text] [Related]
4. All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells.
Harrell JM; Kurek I; Breiman A; Radanyi C; Renoir JM; Pratt WB; Galigniana MD
Biochemistry; 2002 Apr; 41(17):5581-7. PubMed ID: 11969419
[TBL] [Abstract][Full Text] [Related]
5. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
[TBL] [Abstract][Full Text] [Related]
6. FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
McKeen HD; Byrne C; Jithesh PV; Donley C; Valentine A; Yakkundi A; O'Rourke M; Swanton C; McCarthy HO; Hirst DG; Robson T
Cancer Res; 2010 Feb; 70(3):1090-100. PubMed ID: 20103631
[TBL] [Abstract][Full Text] [Related]
7. Evidence for glucocorticoid receptor transport on microtubules by dynein.
Harrell JM; Murphy PJ; Morishima Y; Chen H; Mansfield JF; Galigniana MD; Pratt WB
J Biol Chem; 2004 Dec; 279(52):54647-54. PubMed ID: 15485845
[TBL] [Abstract][Full Text] [Related]
8. Immunophilin chaperones in steroid receptor signalling.
Ratajczak T; Ward BK; Minchin RF
Curr Top Med Chem; 2003; 3(12):1348-57. PubMed ID: 12871166
[TBL] [Abstract][Full Text] [Related]
9. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
10. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
11. Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis.
Solá S; Amaral JD; Borralho PM; Ramalho RM; Castro RE; Aranha MM; Steer CJ; Rodrigues CM
Mol Endocrinol; 2006 Oct; 20(10):2292-303. PubMed ID: 16728529
[TBL] [Abstract][Full Text] [Related]
12. FMS-like tyrosine kinase 3 interacts with the glucocorticoid receptor complex and affects glucocorticoid dependent signaling.
Asadi A; Hedman E; Widén C; Zilliacus J; Gustafsson JA; Wikström AC
Biochem Biophys Res Commun; 2008 Apr; 368(3):569-74. PubMed ID: 18261979
[TBL] [Abstract][Full Text] [Related]
13. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.
Shimizu N; Ouchida R; Yoshikawa N; Hisada T; Watanabe H; Okamoto K; Kusuhara M; Handa H; Morimoto C; Tanaka H
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8555-60. PubMed ID: 15941832
[TBL] [Abstract][Full Text] [Related]
14. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
15. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
16. The hsp56 immunophilin component of steroid receptor heterocomplexes: could this be the elusive nuclear localization signal-binding protein?
Pratt WB; Czar MJ; Stancato LF; Owens JK
J Steroid Biochem Mol Biol; 1993 Sep; 46(3):269-79. PubMed ID: 9831475
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
[TBL] [Abstract][Full Text] [Related]
18. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator.
Heitzer MD; DeFranco DB
Mol Endocrinol; 2006 Jan; 20(1):56-64. PubMed ID: 16141357
[TBL] [Abstract][Full Text] [Related]
20. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
